CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
17.42
0.06%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.09
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026262 %
Charges from full value of position ($-4.99)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026262%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.00404 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.00404%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 17.43
Open 17.51
1-Year Change 20.68%
Day's Range 17.18 - 17.59
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 12, 2024 17.42 0.45 2.65% 16.97 17.76 16.97
Jul 11, 2024 17.43 1.04 6.35% 16.39 17.52 16.22
Jul 10, 2024 16.36 -0.76 -4.44% 17.12 17.13 16.22
Jul 9, 2024 17.11 -0.02 -0.12% 17.13 17.39 16.99
Jul 8, 2024 17.43 0.60 3.57% 16.83 17.44 16.82
Jul 5, 2024 16.83 0.00 0.00% 16.83 16.98 16.41
Jul 3, 2024 17.05 0.52 3.15% 16.53 17.10 16.35
Jul 2, 2024 16.64 -0.22 -1.30% 16.86 17.08 16.60
Jul 1, 2024 16.99 0.73 4.49% 16.26 17.14 16.26
Jun 28, 2024 16.70 -0.35 -2.05% 17.05 17.34 16.27
Jun 27, 2024 17.13 -0.33 -1.89% 17.46 17.46 17.07
Jun 26, 2024 17.44 0.69 4.12% 16.75 17.55 16.75
Jun 25, 2024 17.48 0.45 2.64% 17.03 17.58 17.00
Jun 24, 2024 17.34 -0.13 -0.74% 17.47 17.65 17.24
Jun 21, 2024 17.61 -0.05 -0.28% 17.66 17.88 17.48
Jun 20, 2024 17.70 0.30 1.72% 17.40 17.81 17.37
Jun 18, 2024 17.44 0.46 2.71% 16.98 17.56 16.98
Jun 17, 2024 17.20 0.19 1.12% 17.01 17.25 16.72
Jun 14, 2024 17.18 -0.01 -0.06% 17.19 17.55 17.01
Jun 13, 2024 17.72 0.22 1.26% 17.50 17.76 17.15

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Phibro Company profile

About Phibro Animal Health Corp

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company develops, manufactures and markets a range of products for food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company sells animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through commercial animal feed manufacturers, wholesalers and distributors. Its Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Financial summary

BRIEF: For the six months ended 31 December 2021, Phibro Animal Health Corp revenues increased 11% to $447.4M. Net income decreased 4% to $24M. Revenues reflect Animal Health segment increase of 10% to $291.9M, Mineral Nutrition segment increase of 15% to $121.1M, United States segment increase of 10% to $265.5M, Latin America and Canada segment increase of 16% to $90.7M. Net income was offset by Selling.

Equity composition

Common Stock $.10 Par, 5/06, 30,300 auth., Class A 12,600 issd. Class B 11,888.50. issd. Series A Preferred Stock $100 Par, 9/05, 5,207 auth., 5,207 issd.

Industry: Veterinary Drugs

Glenpointe Centre East, 3Rd Floor
300 Frank W. Burr Blvd., Suite 21
TEANECK
NEW JERSEY 07666
US

People also watch

XRP/USD

0.54 Price
-1.610% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

60,148.70 Price
+2.650% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,411.42 Price
-0.180% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.60

ETH/USD

3,206.68 Price
+1.450% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading